Darifenacin
Back to searchMolecule Structure
Scientific Name
Darifenacin
Description of the Drug
Darifenacin is an M3 muscarinic receptor blocker used to treat urinary incontinence.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00496
http://www.drugbank.ca/drugs/DB00496
Brand Name(s)
Not Available
Company Owner(s)
Allergan Pharmaceuticals International Ltd, Cipla Ltd, Alembic Pharmaceuticals Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Polygen Pharmaceuticals Inc, Xiromed Pharma Espana Sl, Aurobindo Pharma Ltd, Anchen Pharmaceuticals Inc, Torrent Pharmaceuticals Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL56574 | ||
PharmGKB | PA164774901 | ||
Human Metabolome Database | HMDB0014639 | ||
DrugBank | DB00496 | ||
PubChem: Thomson Pharma | 14856314 | ||
PubChem | 444031 | ||
Mcule | MCULE-4616748439 | ||
LINCS | LSM-5995 | ||
Nikkaji | J615.836F | ||
BindingDB | 50109647 | ||
EPA CompTox Dashboard | DTXSID2048290 | ||
DrugCentral | 784 | ||
ChemicalBook | CB1506695 | ||
Guide to Pharmacology | 321 | 319 | |
rxnorm | ENABLEX | DARIFENACIN HYDROBROMIDE | DARIFENACIN |
ChEBI | 391960 | ||
ZINC | ZINC000001996117 |